Listen to Dr. Angela Brown and Recor’s CMO, Dr. Shon Chakrabarti discussion about all things Ultrasound Renal Denervation (uRDN) and learn about Dr. Brown’s experience on treating hypertension patients with uRDN.
Click now to listen: https://t.co/vdUzgmYQYw
Prescription only. Results may vary. Important Safety Information: https://t.co/RQE3vnYwlh
#Hypertension
Clear the Fog: Join us at #TCT25 and catch all the Paradise™ Ultrasound RDN sessions at TCT 2025-where evidence meets experience.
Click now to see Recor’s TCT Scientific Sessions and add them to your calendar: https://t.co/rXLDVPUD3z
#Hypertension#ParadiseURDN
Attending AHA #Hypertension2025 in Baltimore? Join our breakfast symposium and listen to our expert speakers talk about Guidelines and Future of Hypertension: Where does Renal Denervation fit?
Date: Friday September 5, 2025
Time: 7:15am – 7:45am ET
Location: Baltimore Marriott Waterfront, Grand Ballroom 6
Prescription only. Results may vary. Important Safety Information: https://t.co/RQE3vnYwlh
#ParadiseURDN #Hypertension
Nice summary here by @MassDevice highlighting approval of the #Paradise#uRDN system in #Japan#Data integrity, solid #study design - this is how you get to "first in Japan for a medical device indicated for resistant hypertension."
https://t.co/DgjQSI76ic
Drive to Blood Pressure Goal
Paradise™ Ultrasound RDN procedure treats hypertension by calming the overactive renal nerves. When medications and lifestyle changes are not enough, it delivers safe and sustained reductions proven across multiple sham-controlled trials. (1-4)
🔸Effective in presence and absence of medication, and all measures of BP control (1-4)
🔸Avg. 10.4 mmHg systolic BP reduction in 2 months (1)
🔸Enables BP reduction without reliance on patient compliance and concerns with medication side effects
Experience a new path to lowering blood pressure.
Prescription only. Results may vary. Important Safety Information: https://t.co/RQE3vnYwlh
Drive to Blood Pressure Goal
Paradise™ Ultrasound RDN procedure treats hypertension by calming the overactive renal nerves. When medications and lifestyle changes are not enough, it delivers safe and sustained reductions proven across multiple sham-controlled trials. (1-4)
🔶Effective in presence and absence of medication, and all measures of BP control (1-4)
🔶Avg. 10.4 mmHg systolic BP reduction in 2 months (1)
🔶Enables BP reduction without reliance on patient compliance and concerns with medication side effects
Experience a new path to lowering blood pressure.
Prescription only. Results may vary. Important Safety Information: https://t.co/HVIjutrjh4
We were honored to welcome #LimFlow patient John O'Connell, who went from facing major amputation to regaining mobility. His journey highlights why we’re passionate about providing hope to #CLTI patients with limited options.
Watch John's story: https://t.co/DsJxcZV6Fg
We are looking for cardiologist, interventionalist, and EP docs to join our group in southeast Michigan. Busy private practice with opportunities for teaching and research. We can sponsor visas. Must be board certified or eligible. DM me if you are interested.
Better, together 💪🏽
This 💯
“With Inari as part of Stryker, we will be better positioned to help our customers enhance the quality of care and improve the lives of vascular patients worldwide”
#medtech#innovation#vte#pad#clti@InariMedical@CLI_LimFlow
We are excited to announce that Inari Medical entered into a definitive agreement to be acquired by Stryker.
Joining the Stryker family will allow us to build on our tremendous progress in pioneering an entirely new approach to helping patients with Venous Thromboembolism.
Press Release (Important Info): https://t.co/AyCXJ3vqDn
LimFlow by Inari Medical continues to help so many by all the work they do. Listen to our latest episode with Shon Chakrabarti MD MPH and Michael Siah to listen to their story. Available on Spotify and YouTube.
🔗Links below
🎵 https://t.co/qpQIYTMM9N
🎬 https://t.co/paaxyoRJFd
#Vascular #cardiology
#vascularmedicine #vascularsurgery
#interventionalradiology #medtwitter
#medx #VascularPodcast #vascularcare
Confidence is key 🔑 and it also helps to have a group of people you can collaborate with too. Watch our latest episode on @CLI_LimFlow by @InariMedical with @shonmd and @michaelcsiah (at @UTSWMedCenter). Available now on Spotify and YouTube.
🔗Links below
🎵 https://t.co/qpQIYTMM9N
🎬 https://t.co/paaxyoRJFd
#Vascular #cardiology
#vascularmedicine #vascularsurgery
#interventionalradiology #medtwitter
#medx #VascularPodcast #vascularcare
Watch our latest episode on @CLI_LimFlow, by @InariMedical, and feel apart of the community along with @michaelcsiah M.D (at @UTSWMedCenter), @shonmd, @monteromiguel and Lucas Ferrer. Available now on Spotify and YouTube.
🔗Links below
🎵 https://t.co/qpQIYTMekf
🎬 https://t.co/paaxyoRbPF
#Limflow #Vascular #cardiology
#vascularmedicine #vascularsurgery
#interventionalradiology #collab
#MedX #VascularPodcast #vascularcare
Read this weeks newsletter on “@CLI_LimFlow, by @InariMedical, the future of CLTI solutions with Shon Chakrabarti MD MPH and Michael Siah M.D (at @UTSWMedCenter)”. Sign up below to get newsletter updates every Thursday!
https://t.co/aLGEJNAcmb
🚨 New Episode Alert! 🚨
💡 Shon Chakrabarti & Michael Siah - Limflow: The Future of CLTI Solutions
Discover how Limflow's acquisition by Inari is reshaping CLTI treatments, from innovative DBAs to economic impacts on limb salvage programs.
🎙️ Highlights:
🔹 Inari-Limflow synergy revolutionizing vascular care
🔹 Cutting-edge advancements in DBA techniques
🔹 Game-changing research & global collaboration
✨ "Tackling unmet patient needs with purpose-built solutions." - Shon Chakrabarti
@CLI_LimFlow
🎧 Listen now! #Podcast #HealthcareInnovation #CLTI
Dr. Daniel Clair presents PROMISE trial data on a deep venous arterialization panel. @VEITHsymposium@scarolinavasc. Gentlepeople, this is no humbug. #vascsurg
Late-breaking second year results from the PROMISE II trial showed that the LimFlow system achieved strong outcomes for avoiding amputations and promoting limb salvage among “no-option” patients with chronic limb-threatening ischemia (CLTI).
https://t.co/jzNmeWPoH8
One week until our next podiatry and wound care webinar!
Join us for Transforming CLTI Management! This session will cover key topics like addressing the unmet need of CLTI, and identifying and navigating the journey of the TADV patient.
Register here: https://t.co/3JaaMKUgEZ